Stocks › SOLV
Solventum Corp
SOLV·NYSE·
United States·USD
$84.50
-1.30 (-1.52%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
SOLV
Solventum Corp · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
SOLVS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of SOLV by members of U.S. Congress · 24 on record · 15 in the last 12 months
Whale Activity
Position changes in SOLV reported for 2026-09-30 by 966 institutional filers
- Increased238
- New88
- Held227
- Decreased299
- Closed67
- No prior filing47
| Filer | Shares | Value | Change |
|---|---|---|---|
| Independent Franchise Partners LLP | 15.7M | $1.38B | decreased |
| BlackRock, Inc. | 9.6M | $842.4M | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 9.5M | $835.4M | decreased |
| TRIAN FUND MANAGEMENT, L.P. | 8.2M | $726.1M | held |
| DAVIS SELECTED ADVISERS | 6.4M | $565.4M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.2M | $546.7M | decreased |
| STATE STREET CORP | 5.6M | $495.0M | decreased |
| GEODE CAPITAL MANAGEMENT, LLC | 5.0M | $436.3M | increased |
| Boston Partners | 3.6M | $315.4M | decreased |
| Invesco Ltd. | 3.2M | $282.1M | decreased |
| CITADEL ADVISORS LLC | 3.2M | $280.8M | increased |
| DIMENSIONAL FUND ADVISORS LP | 2.5M | $222.4M | increased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by SOLV insiders, by quarter · Form 4
Recent Insider Transactions
111 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Hanson Bryan CChief Executive Officer · Director | Tax withholding | −26.5K | $90.95 | $2.4M | Sep 1, 2026 | Form 4 ↗ |
| Hanson Bryan CChief Executive Officer · Director | Option exercise | +67.3K | — | — | Sep 1, 2026 | Form 4 ↗ |
| Wilcox Mary TChief Accounting Officer | Tax withholding | −728 | $74.41 | $54K | May 13, 2026 | Form 4 ↗ |
| Wilcox Mary TChief Accounting Officer | Option exercise | +2,376 | $0.00 | $0 | May 13, 2026 | Form 4 ↗ |
| Harrington Paul SChief Supply Chain Officer | Tax withholding | −1,678 | $74.41 | $125K | May 13, 2026 | Form 4 ↗ |
| Harrington Paul SChief Supply Chain Officer | Option exercise | +3,960 | $0.00 | $0 | May 13, 2026 | Form 4 ↗ |
| Landucci AmyChief Information Officer | Tax withholding | −2,017 | $74.41 | $150K | May 13, 2026 | Form 4 ↗ |
| Landucci AmyChief Information Officer | Option exercise | +4,422 | $0.00 | $0 | May 13, 2026 | Form 4 ↗ |
| Gomez Tammy LChief Human Resources Officer | Tax withholding | −1,668 | $74.41 | $124K | May 13, 2026 | Form 4 ↗ |
| Gomez Tammy LChief Human Resources Officer | Option exercise | +3,960 | $0.00 | $0 | May 13, 2026 | Form 4 ↗ |
| Kirberger Marcela A.Chief Legal Affairs Officer | Tax withholding | −1,952 | $74.41 | $145K | May 13, 2026 | Form 4 ↗ |
| Kirberger Marcela A.Chief Legal Affairs Officer | Option exercise | +4,488 | $0.00 | $0 | May 13, 2026 | Form 4 ↗ |
| McMillan Wayde D.Chief Financial Officer | Tax withholding | −4,404 | $74.41 | $328K | May 13, 2026 | Form 4 ↗ |
| McMillan Wayde D.Chief Financial Officer | Option exercise | +9,503 | $0.00 | $0 | May 13, 2026 | Form 4 ↗ |
| Hanson Bryan CChief Executive Officer · Director | Tax withholding | −13.5K | $74.41 | $1.0M | May 13, 2026 | Form 4 ↗ |
| Hanson Bryan CChief Executive Officer · Director | Option exercise | +34.3K | $0.00 | $0 | May 13, 2026 | Form 4 ↗ |
| Edwards Shirley AnnDirector | Option exercise | +3,403 | $0.00 | $0 | Apr 30, 2026 | Form 4 ↗ |
| Mily ElizabethDirector | Option exercise | +3,403 | $0.00 | $0 | Apr 30, 2026 | Form 4 ↗ |
| Wilson Darryl L.Director | Option exercise | +3,403 | $0.00 | $0 | Apr 30, 2026 | Form 4 ↗ |
| DeVore Susan D.Director | Option exercise | +3,403 | $0.00 | $0 | Apr 30, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding SOLV · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 4.7M | $360.7M | 0.02% | Jun 30, 2026 |
| VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS | 3.8M | $294.4M | 0.02% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 3.4M | $260.4M | 0.14% | Jun 30, 2026 |
| Disciplined Value Mid Cap Fund John Hancock Funds III | 2.8M | $213.6M | 0.92% | Jun 30, 2026 |
| Invesco S&P 500 Equal Weight ETF Invesco Exchange-Traded Fund Trust | 2.3M | $196.7M | 0.20% | Jul 31, 2026 |
| Fidelity 500 Index Fund Fidelity Concord Street Trust | 1.9M | $174.0M | 0.02% | Aug 31, 2026 |
| VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS | 2.1M | $165.0M | 0.24% | Jun 30, 2026 |
| iShares Core S&P 500 ETF iShares Trust | 2.0M | $156.3M | 0.02% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P 500(R) ETF Trust | 1.8M | $137.6M | 0.02% | Jun 30, 2026 |
| Davis New York Venture Fund DAVIS NEW YORK VENTURE FUND INC | 1.6M | $135.5M | 1.77% | Jul 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list SOLV's shares (CUSIP 83444M101), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming solventum as client
- NAVIGATORS GLOBAL LLC (FORMERLY DC NAVIGATORS, LLC)SOLVENTUM · 2026 Q3 · TRD, MED, HCR, MMM$60K
Filing ↗ - SOLVENTUM CORPORATIONSOLVENTUM CORPORATION · 2026 Q3 · HCR, MMM, DEF, TRD$130K
Filing ↗ - TIBER CREEK GROUPSOLVENTUM CORPORATION · 2026 Q3 · HCR, MMM$60K
Filing ↗ - SOLVENTUM CORPORATIONSOLVENTUM CORPORATION · 2026 Q2 · DEF, TRD, VET, HCR$200K
Filing ↗ - NAVIGATORS GLOBAL LLC (FORMERLY DC NAVIGATORS, LLC)SOLVENTUM · 2026 Q2 · TRD, MED, HCR, MMM$60K
Filing ↗
Government Contracts
Federal awards to Solventum Corp · USAspending
No federal contract awards found for Solventum Corp.
U.S. Patents
Recent USPTO applications naming Solventum Corp
No USPTO patent applications found for Solventum Corp.
Annual Financials
From SOLV's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $8.32B | $8.25B | $8.20B | $8.13B |
| Operating income | $2.18B | $1.04B | $1.69B | $1.69B |
| Net income | $1.56B | $479.0M | $1.35B | $1.34B |
| Diluted EPS | $8.88 | $2.76 | $7.79 | $7.78 |
| Operating cash flow | $369.0M | $1.19B | $1.92B | $1.68B |
| Cash and equivalents | $878.0M | $762.0M | $194.0M | n/a |
| Total assets | $14.29B | $14.46B | $13.94B | n/a |
| Total liabilities | $9.24B | $11.50B | $2.28B | n/a |
| Shareholders' equity | $5.05B | $2.96B | $11.67B | $11.74B |
As Solventum Corp tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 27, 2026 ↗
Stock Splits
Every split and reverse split in the price history
No stock splits in SOLV's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 2.02, 9.01Results of operationsNov 5, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 5, 2026
EDGAR ↗ - 8-K · Items 7.01, 8.01, 9.01Reg FD disclosure · Other eventsAug 5, 2026
EDGAR ↗ - 8-K · Items 5.02Officer / director changeJul 20, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsJun 5, 2026
EDGAR ↗ - 8-K · Items 5.02, 9.01Officer / director changeMay 27, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteMay 20, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 5, 2026
EDGAR ↗
About Solventum Corp
From SEC EDGAR company records
Industry (SIC 3841)Surgical & Medical Instruments & Apparatus
SectorHealthcare
HeadquartersEAGAN, MN
IncorporatedDE
SEC CIK0001964738 ↗
Former names3M Health Care Co








